‌

US Patent 11014913 Pyridazinones as PARP7 inhibitors

Patent 11014913 was granted and assigned to Ribon Therapeutics on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Ribon Therapeutics

Current Assignee

Ribon Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11014913

Date of Patent

May 25, 2021

Patent Application Number

16990677

Date Filed

August 11, 2020

Patent Citations

‌

US Patent 10550105 Pyridazinones as PARP7 inhibitors

Patent Citations Received

‌

US Patent 11691969 Pyridazinones as PARP7 inhibtors

‌

US Patent 11293927 Screening methods for PARP modulators

‌

US Patent 11566020 Pyridazinones as PARP7 inhibitors

Patent Primary Examiner

‌

Deepak R Rao

Patent abstract

The present invention relates to pyridazinones and related compounds which are inhibitors of PARP7 and are useful in the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11014913 Pyridazinones as PARP7 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API